Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hydroxymethylglutaryl-coa Reductase Inhibitors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01245738
What this trial is testing

Effect of Statins on Lipid Levels Following the First Acute Coronary Event (MK-0000-204)

Who this might be right for
DyslipidemiasHypercholesterolemiaHypertriglyceridemia+2 more
Merck Sharp & Dohme LLC 635
Testing effectiveness (Phase 2)Study completedNCT00810979
What this trial is testing

Comparison of SLx-4090 Combined With Statin Therapy Versus Statin Alone in Reducing LDL-C in Patients With Hyperlipidemia

Who this might be right for
Hyperlipidemia
Response Pharmaceuticals 133
Not applicableLooking for participantsNCT07088250
What this trial is testing

Statins for Treatment of Primary Intracerebral Hemorrhage

Who this might be right for
Cerebrovascular DisordersIntracranial HemorrhagesIntracranial Hemorrhage+1 more
The Second Hospital of Anhui Medical University 264
Not applicableStudy completedNCT01483950
What this trial is testing

Evaluation of Patients Treated With HMG-CoA Reductase Inhibitors to Reach Cholesterol Target Values

Who this might be right for
Hypercholesterolaemia
AstraZeneca 800
Not applicableStudy completedNCT01152073
What this trial is testing

Nutraceutical Drinks For Cholesterol (Evaluating Effectiveness and Tolerability)

Who this might be right for
Hyperlipidemia
Healthy Drink Discoveries, Inc. 79
Post-approval studies (Phase 4)Not Yet RecruitingNCT07254221
What this trial is testing

Rosuvastatin for Prevention of Anthracycline-induced Cardiac Dysfunction in Breast Cancer Patients

Who this might be right for
Anthracycline-induced Cardiac ToxicityBreast CancerAnthracycline Related Cardiotoxicity in Breast Cancer+1 more
Shiraz University of Medical Sciences 400
Not applicableNot Yet RecruitingNCT07515560
What this trial is testing

Efficacy and Safety of Baroezet Tablet in Korean Patients With Dyslipidemia: A Prospective Observational Study

Who this might be right for
Dyslipidemia
Daewoong Pharmaceutical Co. LTD. 12,000
Not applicableStudy completedNCT00546559
What this trial is testing

Differential Metabolic Effects of Statins

Who this might be right for
Hypercholesterolemia
Gachon University Gil Medical Center
Large-scale testing (Phase 3)Looking for participantsNCT05796973
What this trial is testing

Measuring Oncological Value of Exercise and Statin

Who this might be right for
Prostate CancerBreast CancerKidney Cancer+9 more
Tampere University Hospital 240
Testing effectiveness (Phase 2)Study completedNCT04472637
What this trial is testing

Atorvastatin Effects On Arterial Stiffness In Hemodialysis

Who this might be right for
Arterial Stiffness
Alexandria University 50
Not applicableStudy completedNCT03915795
What this trial is testing

Statins Study in Kawasaki Disease Children With Coronary Artery Abnormalities

Who this might be right for
Kawasaki DiseaseCoronary Artery Abnormalities
Children's Hospital of Fudan University 30
Very early researchEnded earlyNCT02331095
What this trial is testing

Statin Use in Patients With Acute VTE

Who this might be right for
Venous Thromboembolism
Ohio State University 21
Large-scale testing (Phase 3)Study completedNCT00844402
What this trial is testing

Safety and Efficacy of Long-Term Treatment With Atorvastatin in Patients With Primary Biliary Cirrhosis

Who this might be right for
Primary Biliary CirrhosisHypercholesterolemia
Medical University of Graz 40
Early research (Phase 1)Study completedNCT00966472
What this trial is testing

Phase I Study of a Statin + Erlotinib for Advanced Solid Malignancies With Focus on Squamous Cell Carcinomas and NSCLC

Who this might be right for
Squamous Cell CarcinomaNon-Small Cell Lung Cancer
Ottawa Hospital Research Institute 24
Early research (Phase 1)Ended earlyNCT01651273
What this trial is testing

A Safety Study of BMS-852927 in Subjects With Hypercholesterolemia

Who this might be right for
Hypercholesterolemia
Bristol-Myers Squibb 97
Not applicableLooking for participantsNCT05725096
What this trial is testing

Role of Coronary CTA on Lipid Management and Risk Factors Control in an Asymptomatic Chinese Population

Who this might be right for
StatinCardiovascular Risk FactorsPrimary Prevention+1 more
Zhang longjiang,MD 3,400
Post-approval studies (Phase 4)UnknownNCT01490229
What this trial is testing

Ezetimibe Versus Nutraceuticals in Statin-intolerant Patients

Who this might be right for
Coronary Artery Disease
University of Roma La Sapienza 100
Post-approval studies (Phase 4)Study completedNCT01200056
What this trial is testing

Virtual Histology Findings and Effects of Varying Doses of Atorvastatin Treatment

Who this might be right for
Coronary DiseaseUltrasonography, InterventionalHydroxymethylglutaryl-CoA Reductase Inhibitors
Prof. Stephen Lee 40
Post-approval studies (Phase 4)Looking for participantsNCT05845424
What this trial is testing

High-intensity Statin and Ezetimibe Therapy for Asymptomatic Patients With Positive Coronary Calcium

Who this might be right for
Coronary Artery CalcificationMetabolic SyndromeDyslipidemias
Samsung Medical Center 6,000
Very early researchStudy completedNCT00783042
What this trial is testing

Exploratory Study of Coronary Flow Reserve Measurements, a Non-Invasive Method for Coronary Function Measurements

Who this might be right for
AtherosclerosisInflammatory Activity in Coronary Arteries
AstraZeneca 80
Next Page